| Financial Year |
March 31 2023 |
| Monetary Funds |
790,367,082.96 |
| Held-for-trading Financial Assets |
100,950,000.00 |
| Notes Receivable |
60,779,129.58 |
| Accounts Receivable |
1,966,850,070.30 |
| Advances to Suppliers |
390,089,567.56 |
| Other Receivables |
13,532,447.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,760,597,980.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,117,758.31 |
| Other Current Assets |
157,776,257.84 |
| Total Current Assets |
6,447,136,117.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
26,736,559.15 |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,211,653.52 |
| Fixed Assetes |
2,137,927,791.48 |
| Under-construction Projects |
694,886,354.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
273,385,187.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
83,399,931.39 |
| Deferred Income Tax Assets |
40,973,881.25 |
| Other Non-Current Assets |
151,826,516.00 |
| Sub-Total of Non-Current Assets |
3,470,580,472.68 |
| Total Assets |
9,917,716,590.62 |
| Short-Term Loans |
305,297,222.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,100,291,478.21 |
| Accounts Payable |
2,888,379,651.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,807,648.65 |
| Taxes Payable |
107,530,897.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,013,059.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
122,350,832.24 |
| Other Current Liabilities |
53,536,629.58 |
| Sub-Total of Current Liabilities |
4,766,276,038.39 |
| Long-term Loans |
759,768,800.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,002,010.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
865,049,466.93 |
| Total Liabilities |
5,631,325,505.32 |
| Paid-In Capital(Or Share Stock) |
487,301,971.00 |
| Capital Surplus |
2,108,121,835.51 |
| Surplus Reserve |
149,538,099.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,474,815,111.20 |
| Minority Stockholder's Interest |
51,490,475.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,234,900,609.88 |
| Owner's Equity（Stockholder's Equity） |
4,286,391,085.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,917,716,590.62 |
